Pharma

Women’s Reproductive Health Pharma Company ObsEva Appoints Clive Bertram as Chief Commercial Officer

ObsEva, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEva’s Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity.…

Menopause: TherapeuticsMD Launches a Bold, New Campaign Promoting Imvexxy, Its Estrogen Softgel Insert That Treats Vaginal Dryness

“Your vagina is queen. Imvexxy is her ally. Long may she reign.” Imvexxy by TherapeuticsMD is the only bio-identical estrogen softgel insert available today. It was first approved in May 2018, when the drug launched with a small campaign. Last week, however, Imvexxy, made a comeback with a bold, new campaign: “Reign”. The new video ad is period-drama (think Bridgerton) inspired and…